Alí Duarte‐García

The 2023 <scp>ACR</scp>/<scp>EULAR</scp> Antiphospholipid Syndrome Classification Criteria

Medha Barbhaiya, Stéphane Zuily, Ray Naden et al. · Arthritis & Rheumatology · 2023 · 431 citations · Full text

Medicine, Internal Medicine, Autoimmunity +15

2023 ACR/EULAR antiphospholipid syndrome classification criteria

Medha Barbhaiya, Stéphane Zuily, Ray Naden et al. · Annals of the Rheumatic Diseases · 2023 · 424 citations · Full text

Life Sciences, Hematology, Internal Medicine +17

The Epidemiology of Antiphospholipid Syndrome: A Population‐Based Study

Alí Duarte‐García, Cynthia S. Crowson, Shreyasee Amin et al. · Arthritis & Rheumatology · 2019 · 285 citations · Full text

Life Sciences, Immunology, Clinical Epidemiology +16

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet et al. · Annals of the Rheumatic Diseases · 2021 · 241 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil et al. · JAMA Network Open · 2021 · 116 citations · Full text

Medicine, Immunology, Pharmacotherapy +13